Science Explorer Interactive view Map
Company · Boulder · United States

Nivalis Therapeutics (United States)

nivalis.comROR OpenAlex
World rank, all time
#25,891
of 42,892
Rank in United States
#5,547
of 8,685
Research works
124
▼ 68% vs 2013–17
Citations
9.5k
76.8 per fractional work
Top-10% rate
3.3%
record average 16.5%
Open access
36%
world 28%

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Agricultural and Biological Sciences: 0.69× its world share, 0 worksAgricultural and Bio…Biochemistry, Genetics and Molecular Biology: 1.74× its world share, 0 worksBiochemistry, Geneti…Immunology and Microbiology: 1.30× its world share, 0 worksImmunology and Micro…Neuroscience: 1.01× its world share, 0 worksNeurosciencePharmacology, Toxicology and Pharmaceutics: 6.19× its world share, 0 worksPharmacology, Toxico…Chemistry: 2.78× its world share, 0 worksChemistryMedicine: 4.05× its world share, 4 worksMedicine1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Pharmacology, Toxicology and Pharmaceutics, 6.2×. Every wedge is a field page.

Which keywords describe research at Nivalis Therapeutics (United States)?

By fractional works in all years, weighted toward what it does more of than the world: Nanoparticles, Biosensors, Ribosome, Translation, Self-Assembly, aptamers, DNA nanotechnology and Therapeutic Targets.

▲ more of its work than of the world’s◆ about the world’s share▼ less than the world’s

Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 40 words, with their numbers
  1. Nanoparticles19▲ 11×6 topics
  2. Biosensors16▲ 23×3 topics
  3. Ribosome15▲ 125×1 topic
  4. Translation15▲ 60×1 topic
  5. Self-Assembly15▲ 31×2 topics
  6. DNA nanotechnology15▲ 119×1 topic
  7. aptamers15▲ 119×1 topic
  8. Therapeutic Targets12▲ 41×4 topics
  9. Nucleic Acids12▲ 128×2 topics
  10. Genomic Stability12▲ 101×2 topics
  11. Antisense Oligonucleotides11▲ 108×2 topics
  12. DNA Structure11▲ 145×1 topic
  13. G-Quadruplexes11▲ 145×1 topic
  14. Inflammation11▲ 3.8×19 topics
  15. Glycosylation7▲ 24×3 topics
  16. Gene Therapy6▲ 19×3 topics
  17. Monoclonal Antibodies6▲ 32×3 topics
  18. Cancer6▲ 3.2×11 topics
  19. RNA Interference6▲ 40×1 topic
  20. siRNA Delivery6▲ 60×1 topic
  21. Therapeutic Antibodies6▲ 35×2 topics
  22. Oxidative Stress5▲ 2.3×12 topics
  23. Antibody Engineering5▲ 41×1 topic
  24. Fc Receptors5▲ 41×1 topic
  25. Cancer Progression5▲ 17×4 topics
  26. Chemotherapy4▲ 4.8×8 topics
  27. Reactive Oxygen Species4▲ 6.5×7 topics
  28. Angiogenesis4▲ 7.5×5 topics
  29. Metabolism4▲ 4.5×8 topics
  30. Extracellular Matrix4▲ 12×3 topics
  31. Gene Expression Regulation3▲ 24×2 topics
  32. RNA methylation3▲ 33×1 topic
  33. m6A-seq3▲ 33×1 topic
  34. Antiretroviral Therapy3▲ 11×3 topics
  35. Cell Signaling3▲ 7.5×5 topics
  36. Drug Discovery3▲ 6.1×4 topics
  37. Medicinal Chemistry3▲ 6.3×5 topics
  38. Cardiovascular Diseases2▲ 16×1 topic
  39. Cell Adhesion2▲ 21×1 topic
  40. Nitric Oxide2▲ 34×1 topic

Which research topics does Nivalis Therapeutics (United States) publish most on?

By volume in 2022–2025: HER2/EGFR in Cancer Research, Cancer Treatment and Pharmacology, Monoclonal and Polyclonal Antibodies Research and Chronic Myeloid Leukemia Treatments.

HER2/EGFR in Cancer Rese…1HER2/EGFR in Cancer Research: 1 fractional worksCancer Treatment and Pharmacology: 0 fractional worksMonoclonal and Polyclona…0Monoclonal and Polyclonal Antibodies Research: 0 fractional worksChronic Myeloid Leukemia…0Chronic Myeloid Leukemia Treatments: 0 fractional worksMuscle Physiology and Disorders: 0 fractional worksCardiomyopathy and Myosin Studies: 0 fractional worksChronic Lymphocytic Leuk…0Chronic Lymphocytic Leukemia Research: 0 fractional worksAdipose Tissue and Metabolism: 0 fractional worksQuinazolinone synthesis and applications: 0 fractional worksPlatelet Disorders and Treatments: 0 fractional works
OncologyRadiology, Nuclear Medicine and ImagingHematologyMolecular Biology4 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 HER2/EGFR in Cancer Research Oncology 1 works
  2. 2 Cancer Treatment and Pharmacology Oncology 0 works
  3. 3 Monoclonal and Polyclonal Antibodies Research Radiology, Nuclear Medicine and Imaging 0 works
  4. 4 Chronic Myeloid Leukemia Treatments Hematology 0 works
  5. 5 Muscle Physiology and Disorders Molecular Biology 0 works
  6. 6 Cardiomyopathy and Myosin Studies Cardiology and Cardiovascular Medicine 0 works
  7. 7 Chronic Lymphocytic Leukemia Research Genetics 0 works
  8. 8 Adipose Tissue and Metabolism Physiology 0 works
  9. 9 Quinazolinone synthesis and applications Organic Chemistry 0 works
  10. 10 Platelet Disorders and Treatments Hematology 0 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available36.5%not open63.5%

World: 28% of research is openly available.

with international co-authors9.8%domestic only90.2%

World: 19% is written across borders.

How has Nivalis Therapeutics (United States)'s research output changed?

Output in 2018–2022 was 68% lower than in 2013–2017.

199520002005201020152020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in Boulder

All research institutions in Boulder

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.